Suppr超能文献

沉默长链非编码RNA linc00689通过靶向miR-129-5p/NUSAP1抑制骨肉瘤细胞的生长和侵袭。

Silencing long non-coding RNA linc00689 suppresses the growth and invasion of osteosarcoma cells by targeting miR-129-5p/NUSAP1.

作者信息

Zhang Ling, Song Jingtao, Xu Xin, Sun Donghong, Huang Huiting, Chen Yang, Zhang Tao

机构信息

Department of Orthopaedics, Huabei Petroleum General Hospital, Renqiu, China.

Department of Orthopaedics, Tianjin Beichen District Traditional Chinese Medicine Hospital, Tianjin, China.

出版信息

Int J Exp Pathol. 2025 Mar;106(2):e12524. doi: 10.1111/iep.12524.

Abstract

Long non-coding RNAs (lncRNAs) have been reported to play a critical role in the progression and metastasis of osteosarcoma. Recently, long intergenic non-protein coding RNA 689 (linc00689) has been shown to be involved in glioma. However, the precise role of linc00689 in osteosarcoma is unknown. In this study, our data demonstrated that silencing linc00689 by siRNA markedly suppressed the proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) of MG63 and SAOS-2 cells. Bioinformatics analysis and dual-luciferase reporter assay revealed that linc00689 could bind to miR-129-5p. Moreover, NUSAP1 was a target of miR-129-5p and positively regulated by linc00689. Further, NUSAP1 overexpression enhanced MG63 cell behaviour and abolished the inhibitory effects of linc00689 knockdown on the proliferation, migration, invasion and EMT of MG63 cells. In conclusion, linc00689 exerts an oncogenic role in the progression of osteosarcoma, which works via the miR-129-5p/NUSAP1 axis.

摘要

据报道,长链非编码RNA(lncRNAs)在骨肉瘤的进展和转移中起关键作用。最近,长链基因间非编码RNA 689(linc00689)已被证明与胶质瘤有关。然而,linc00689在骨肉瘤中的确切作用尚不清楚。在本研究中,我们的数据表明,通过siRNA沉默linc00689可显著抑制MG63和SAOS-2细胞的增殖、迁移、侵袭和上皮-间质转化(EMT)。生物信息学分析和双荧光素酶报告基因检测显示,linc00689可与miR-129-5p结合。此外,NUSAP1是miR-129-5p的靶标,并受linc00689正向调控。进一步研究发现,NUSAP1过表达增强了MG63细胞的行为,并消除了linc00689敲低对MG63细胞增殖、迁移、侵袭和EMT的抑制作用。总之,linc00689在骨肉瘤进展中发挥致癌作用,其通过miR-129-5p/NUSAP1轴起作用。

相似文献

本文引用的文献

2
Targeted anti-angiogenesis therapy for advanced osteosarcoma.晚期骨肉瘤的靶向抗血管生成治疗
Front Oncol. 2024 Aug 26;14:1413213. doi: 10.3389/fonc.2024.1413213. eCollection 2024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验